Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Acasta Partners UK

Latest statistics and disclosures from Acasta Partners UK's latest quarterly 13F-HR filing:

Top 5 stock holdings are Alibaba Group 0.500 01-Jun-2031, Lithium Amers Corp, Jazz Investments I, Mcewen, HYG, and represent 78.63% of Acasta Partners UK's stock portfolio.
Added to shares of these 6 stocks: Jazz Investments I (+$28M), OPI (+$8.6M), Viridian Therapeutics (+$5.7M), Celcuity, HBM, NFE.
Started 5 new stock positions in OPI, Viridian Therapeutics, NFE, Celcuity, Jazz Investments I.
Reduced shares in these 7 stocks: Alibaba Group 0.500 01-Jun-2031 (-$6.3M), HIVE, HYG, Blue Moon Metals, BMM, DSX.WS, CORZW.
Sold out of its positions in Blue Moon Metals, CORZW, HIVE, DSX.WS.
Acasta Partners UK was a net buyer of stock by $35M.
Acasta Partners UK has $223M in assets under management (AUM), dropping by 17.77%.
Central Index Key (CIK): 0002090007

Tip: Access up to 7 years of quarterly data

Positions held by Acasta Partners UK consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Acasta Partners UK

Acasta Partners UK holds 19 positions in its portfolio as reported in the September 2026 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Alibaba Group Holding Cv Bond (Principal)	37.9	$85M	-6%	68M	1.25	View chart
Lithium Argentina Cv Bond (Principal)	13.9	$31M		32M	0.99	View chart
Jazz Investments I Cv Bond (Principal)	12.7	$28M	NEW	18M	1.62	View chart
McEwen Cv Bond (Principal)	8.3	$19M		10M	1.85	View chart
iShares iBoxx $ High Yield Corporate Bond ETF Ord (HYG)	5.8	$13M	-15%	168k	77.21	View chart
Ramaco Resources Cv Bond (Principal)	5.7	$13M		20M	0.63	View chart
Office Properties Income Trust Ord (OPI)	3.9	$8.6M	NEW	542k	15.93	View chart
Viridian Therapeutics Cv Bond (Principal)	2.6	$5.7M	NEW	5.0M	1.15	View chart
Hudbay Minerals Ord (HBM)	2.4	$5.3M	+75%	197k	26.70	View chart
Celcuity Cv Bond (Principal)	1.6	$3.6M		2.0M	1.81	View chart
Celcuity Cv Bond (Principal)	1.1	$2.4M	NEW	2.5M	0.97	View chart
Cameco Corporation Ord (CCJ)	0.9	$1.9M		22k	86.69	View chart
Arrowhead Pharmaceuticals Cv Bond (Principal)	0.7	$1.5M		1.5M	1.03	View chart
USA Rare Earth Class A (USAR)	0.6	$1.4M		98k	14.08	View chart
Uranium Energy Corp. Ord (UEC)	0.6	$1.3M		143k	9.45	View chart
IsoEnergy Ord (ISOU)	0.6	$1.3M		151k	8.90	View chart
NexGen Energy Ord (NXE)	0.5	$1.2M		132k	9.12	View chart
Blue Moon Metals Ord (BMM)	0.2	$499k	-22%	100k	4.99	View chart
New Fortress Energy Class A (NFE)	0.1	$183k	NEW	29k	6.27	View chart

Past Filings by Acasta Partners UK

SEC 13F filings are viewable for Acasta Partners UK going back to 2026

Acasta Partners UK 2026 Q3 filed Oct. 5, 2026
Acasta Partners UK 2026 Q2 filed July 6, 2026
Acasta Partners UK 2026 Q1 filed May 14, 2026

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z